Effectiveness of implementation of lasolvan for comprehensive treatment of new cases with pulmonary TB

G. Smailova, G. Sagintayeva, R. Keshileva (Almaty, Kazakhstan)

Source: Annual Congress 2007 - Epidemiology of tuberculosis II
Session: Epidemiology of tuberculosis II
Session type: Thematic Poster Session
Number: 3833
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Smailova, G. Sagintayeva, R. Keshileva (Almaty, Kazakhstan). Effectiveness of implementation of lasolvan for comprehensive treatment of new cases with pulmonary TB. Eur Respir J 2007; 30: Suppl. 51, 3833

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
New approaches for evaluation of treatment effectiveness among patients with pulmonary TB under DOTS implemented conditions
Source: Eur Respir J 2002; 20: Suppl. 38, 368s
Year: 2002

Monitoring of new pulmonary TB patients: detection and treatment
Source: Annual Congress 2009 - Clinical tuberculosis
Year: 2009

Treatment outcomes of new cases of polyresistant pulmonary TB with second line anti-TB drugs in DOTS-Plus regimen
Source: Eur Respir J 2002; 20: Suppl. 38, 359s
Year: 2002

The efficiency of treatment of new cases of pulmonary TB in the hospital setting
Source: Eur Respir J 2001; 18: Suppl. 33, 339s
Year: 2001

Application of psychotherapy in medical treatment of patients with first revealed pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 504s
Year: 2006

Surgical treatment of first found pulmonary tuberculosis at ineffectiveness of DOTS therapy
Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions
Year: 2011

Efficacy of different preoperational treatment in patients with destructive pulmonary TB
Source: Eur Respir J 2005; 26: Suppl. 49, 688s
Year: 2005

Safety and efficacy of home-based pulmonary rehabilitation in patients with pulmonary hypertension: Feasibility study of 12 cases
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020

The effectiveness of the introduction of the updated treatment regimens and microbiological diagnostics MDR/XDR tuberculosis
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019

Treatment results of new cases of sputum-positive pulmonary tuberculosis with standard chemotherapeutical regimen
Source: Eur Respir J 2002; 20: Suppl. 38, 367s
Year: 2002

Current approaches to the prevention of tuberculosis in patients receiving immunosuppressants
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021

Effectiveness of pulmonary rehabilitation programs on persistent asthma.
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018

Clinical efficacy of new anti-TB drug ²tubelon² during complex chemotherapy in patients with first-time diagnosed destuctive pulmonary TB
Source: Eur Respir J 2006; 28: Suppl. 50, 8s
Year: 2006

Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities
Source: Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020
Year: 2021

Limitations of immune-based diagnostics in patients suspected for pulmonary tuberculosis
Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis
Year: 2009

Efficacy of a standard chemotherapy regimen in the management of sputum-positive pulmonary TB relapses
Source: Eur Respir J 2003; 22: Suppl. 45, 41s
Year: 2003

Monitoring results of diagnostics and treatment of new TB patients in Uliyanovsk region
Source: Annual Congress 2010 - Global tuberculosis control
Year: 2010

Effectiveness of the intensive phase of chemotherapy in pulmonary TB patients with primary drug resistance
Source: Eur Respir J 2006; 28: Suppl. 50, 290s
Year: 2006

Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018